Allergy Diagnosis and Management and Diagnosis beyond Covid-19

08 July 2020

Last month PCM Scientific held five country-specific webinars on ”Allergy diagnosis and management during and beyond Covid-19”, which will be archived on the Alliance Allergy platform.

The aim was to explain the main learnings from EAACI guidelines alongside country-specific guidance and to support primary care doctors and allergy specialists in their clinical practice. The main objectives were to learn practical tips to optimise allergy diagnosis and management beyond the Covid-19 pandemic, and to be able to conduct a diagnosis to differentiate Covid-19 from allergic rhinitis.

The Alliance Allergy platform currently hosts a series of modules, case studies and resources to improve clinical knowledge surrounding the diagnosis of allergic diseases, the administration of appropriate care and the recognition of when specialised care is required.